Report #2829839

Received Mar 6, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: MO
Recovered: Unknown
Vaccinated: Feb 25, 2025
Onset: Feb 25, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	UNK	—	—

Symptoms (2)

No adverse eventProduct administered to patient of inappropriate age

Symptom narrative

15 Year Received Heplisav-B; Initial report received on 25-Feb-2025. A nurse reported that a 15-year-old male patient received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization while at an inappropriate age. No medical history or concomitant medications were reported. On 25-Feb-2025, the patient received a dose of a hepatitis B vaccine [HEPLISAV-B (NDC # 43528-002-01, lot #, expiration date, route, and site not available). The patient was 15 years old when he received HEPLISAV-B. There were no adverse events reported. No additional information was reported. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.